Crossmark

miR-378, miR-20a, and miR-520a-3p can be used in a novel serum prognostic panel for cervical cancer

Published Online: 2025-10-17

Authors

Li, Shuping

Li, Huiying

Li, Yan

Cui, Ying https://orcid.org/0009-0004-6285-3663
Funding

Funding for this research was provided by:

the doctoral research initiation fund project (Contract grant number: 2024-HQBS-01)

the basic scientific research projects of provincial higher education institutions in Heilongjiang Province (Contract grant number: 2023-KYYWF-0927)
License Information

Text and Data Mining valid from 2025-10-17

Version of Record valid from 2025-10-17
More Information

Article History

Received: 17 March 2025

Accepted: 15 September 2025

First Online: 17 October 2025

Declarations

:

: The authors declare no competing interests.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Hongqi Hospital Affiliated to Mudanjiang Medical University (No. 2024028).

: Informed consent was obtained from all individual participants included in the study.

: Patients signed informed consent regarding publishing their data.

Document is current